Vor Biopharma
Clinical trials sponsored by Vor Biopharma, explained in plain language.
-
New drug trial aims to tame autoimmune attack in Sjögren's disease
Disease control Recruiting nowThis study is testing whether an investigational drug called telitacicept can better control the symptoms of active primary Sjögren's disease compared to a placebo. It will involve about 250 adult participants who have the disease and will track changes in their symptoms, fatigue…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug trial aims to tame debilitating Muscle-Weakening disease
Disease control Recruiting nowThis study is testing an investigational drug called telitacicept to see if it can safely reduce symptoms and improve daily life for adults with generalized myasthenia gravis (gMG), an autoimmune disease that causes severe muscle weakness. About 180 participants will receive eith…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC